Then, we assessed the expression pattern of CEBPG between AML patients and healthy controls in a public transcriptomic dataset (GSE114868) [37], and found that CEBPG was more highly expressed in AML samples (Fig. 1b) relative to that in healthy control samples (the differentially expressed genes between AML and control samples in dataset GSE114868 are listed in Additional file 1: Table S1). Here, CEBPG is linked to acute myeloid leukemia.